Bausch expands US plant US-based Bausch Advanced Technology, a specialist supplier of pharmaceutical machinery, has announced plans to expand its facility in Clinton, Connecticut. The firm said that the move, which will double the size of the current plant, will increase both its manufacturing capacity and offer more space for its contract engineering, pilot testing, parts and support services and R&D capabilities. Bausch commented that the proposed expansion, coupled with its existing plants in Switzerland, Germany and Brazil, will allow it to maintain its position in the market and stay ahead of increasing demand. Sartorius Stedim opens Singapore support centre France's Sartorius Stedim Biotech, which offers development, quality assurance and production process services to the biopharmaceutical industry, has opened a new Technical support centre in Singapore. The firm said that it will use the site to provide support to customers wishing to relocate to the region. The facility has been set up in partnership with the Temasek Polytechnic University. The PASS (process application service Singapore) centre, which comprises a complete pilot plant station, will offer specific training courses and seminars covering theoretical principles and process optimization. Facilities at the plant include traditional cell culture reactions, downstream technology equipment, disposable bioreactors, mixing equipment and aseptic fluid filling management systems. Joerg Lindenblatt, Sartorius' vice president of Asian sales, said: "PASS is another important component of our global support network…it allows us to ensure consistent quality and technical expertise for our global key accounts." Sartorius' move is likely to be welcomed by Singapore's Economic Development Board (EDB) which reported that pharmaceutical manufacturing output was down 1.7 per cent year and 1.5 per cent on year for the final two months of 2007, respectively. RFCL unveils integrated manufacturing plant India's RFCL, which provides in vitro diagnostics, animal health products, laboratory solutions and custom synthesis services, has opened an integrated manufacturing plant for the production of human diagnostics reagents and veterinary pharmaceutical products. The 91,000 sq ft facility, which conforms to US Food and Drug Administration (FDA) and World Health Organization good manufacturing practice (GMP) standards, has the capacity to manufacture 10 million tablets, 3 million dosages of liquids and 12 hundred thousand doses of powder injectables a year. RFCL's managing director, Sushil Mehta, said that "integrating this manufacturing capacity along with the synergistic capability that we have acquired out of Bremer Pharma in Germany puts together a significant manufacturing strength." Hapman launches SolidQuid Michigan-based bulk material handling equipment specialist Hapman, has launched a new solid/liquid bulk delivery system that has potential applications in the pharmaceutical industry. The SolidQuid system is designed to facilitate the delivery of bulk solid and liquid ingredients to manufacturing lines, without the need for human intervention. The apparatus can be directly incorporated into existing production setups without the need for additional conveyor units. Helsinn to use TrackWise for QA management Helsinn Healthcare will use Sparta Systems' TrackWise system to standardize its quality assurance practices at its home base in Switzerland and its sites in Ireland. The firm explained that TrackWise will allow it to create a single, corporation-wide standard. Helsinn's chief operating officer, Giorgio Calderari, said: "the TrackWise system will allow us to harmonize all quality assurance procedures across our businesses for better performance." The company plans a staged rollout of TrackWise across the organization to support a number of core processes including unplanned deviations, Change Control, corrective and preventative action (CAPA), out-of-specification (and out-of-trend), complaints, audit, training and supplier qualification.
in-PharmaTechnologist.com's periodic round-up of developments in the pharmaceutical manufacturing space includes news of three new facilities, plus some interesting product launches and updates.